GLYLINA M

GLYLINA-M by Voithea Healthcare is a thoughtfully formulated anti-diabetic combination featuring Linagliptin 2.5mg and Metformin 500mg. This dual-action tablet effectively improves glycemic control by enhancing insulin secretion, reducing hepatic glucose production, and improving insulin sensitivity.

Designed for patients with type 2 diabetes, GLYLINA-M supports comprehensive blood sugar management with a convenient dosing regimen. Its synergistic mechanism offers a powerful therapeutic advantage while minimizing the risk of hypoglycemia, reflecting Voithea Healthcare’s dedication to advanced and patient-centric diabetic care.